Search research articles
Contact Us
Filters
Showing results (281-290 of 328) with videos related to
Page
of 33
Sort By:
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
British Journal of Haematology
|
December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
Brian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Blood
|
August 11, 2018
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements
Rebecca A Luchtel, Surendra Dasari, Naoki Oishi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2025
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Loretta J Nastoupil, Clark R Andersen, Amy Ayers, et al.
Blood
|
May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphoma
Rebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
Eclinicalmedicine
|
April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 328) with videos related to
Sort By:
Page
of 33
Nature Communications
|
August 8, 2024
Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation
Matthew E Stokes, Kerstin Wenzl, C Chris Huang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Hervé Ghesquieres, Susan L Slager, Fabrice Jardin, et al.
British Journal of Haematology
|
December 22, 2018
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma
Brian T Hill, Loretta Nastoupil, Allison M Winter, et al.
Blood
|
April 3, 2015
The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma
Rebecca L Boddicker, N Sertac Kip, Xiaoming Xing, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 19, 2023
Multiomic Analysis Identifies a High-Risk Metabolic and TME Depleted Signature that Predicts Early Clinical Failure in DLBCL
Kerstin Wenzl, Matt Stokes, Joseph P Novak, et al.
Blood Cancer Journal
|
June 20, 2024
Multiomic analysis identifies a high-risk signature that predicts early clinical failure in DLBCL
Kerstin Wenzl, Matthew E Stokes, Joseph P Novak, et al.
Blood
|
August 11, 2018
Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with <i>DUSP22</i> rearrangements
Rebecca A Luchtel, Surendra Dasari, Naoki Oishi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 18, 2025
Real-World Effectiveness of Chemoimmunotherapy and Novel Therapies for Patients With Relapsed/Refractory Aggressive Large B-Cell Lymphoma
Loretta J Nastoupil, Clark R Andersen, Amy Ayers, et al.
Blood
|
May 19, 2019
Recurrent <i>MSC</i> <sup>E116K</sup> mutations in ALK-negative anaplastic large cell lymphoma
Rebecca A Luchtel, Michael T Zimmermann, Guangzhen Hu, et al.
Eclinicalmedicine
|
April 18, 2024
Marginal zone lymphoma international prognostic index: a unifying prognostic index for marginal zone lymphomas requiring systemic treatment
Luca Arcaini, Côme Bommier, Juan Pablo Alderuccio, et al.
Page
of 33